"Panobinostat is active in relapsed/refractory diffuse large B cell lyphoma (DLBCL): A randomized phase II study" by Zuanel Diaz

Selected Works of Zuanel Diaz

Follow Contact

Presentation

Panobinostat is active in relapsed/refractory diffuse large B cell lyphoma (DLBCL): A randomized phase II study

American Association for Clinical Oncology (2013)

Zuanel Diaz

Disciplines

Medicine and Health Sciences,
Neoplasms and
Oncology

Publication Date

June, 2013

Location

Chicago, IL

Comments

Additional authors: Assouline SE, Nielsen TH, Mann K, MacDonald D, Tosikyan AA, Rousseau C, Johnson N, Crump M.

Citation Information

Zuanel Diaz. "Panobinostat is active in relapsed/refractory diffuse large B cell lyphoma (DLBCL): A randomized phase II study" American Association for Clinical Oncology (2013)
Available at: http://works.bepress.com/zuanel-diaz/29/